01P — Medpace Holdings Share News
0.000.00%
Last trade - 00:00- €13.22bn
- €12.65bn
- $2.53bn
Medpace Holdings up on beating Q3 estimates
Medpace Holdings Inc expected to post earnings of $1.47 a share - Earnings Preview
Contract research firms fall as Syneos sees large pharma award delays
Medpace Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: Medpace Holdings, Inc. Reports Second Quarter 2022 Results
Medpace Holdings Inc expected to post earnings of $1.31 a share - Earnings Preview
CROs rise after IQVIA's upbeat results
U.S. RESEARCH ROUNDUP- Bloom Energy, Northern Trust, West Pharmaceutical Services
Nasdaq Biotech Index falls, Protagonist Therapeutics top loser
Medpace Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Medpace Holdings Reports Q1 Earnings Per Share Of $1.69
Contract researchers fall after Jefferies flags demand concerns
Charles River Laboratories falls as Jefferies downgrades on demand concerns
Medpace Holdings Inc expected to post earnings of $1.26 a share - Earnings Preview
Brief: Medpace Holdings Says On March 15, Entered Into Amendment No. 4 To Loan Documents With PNC Bank, National Association On Co's Unsecured Credit Facility
Baird says CROs to benefit as biotech funding 'fog' lifts
Biotech related concerns are overblown, says Baird after decline in CRO stocks
Brokerages say IQVIA unlikely to take big hit from funding decline
Medpace Holdings Inc reports results for the quarter ended in December - Earnings Summary